Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

312.00p
   
  • Change Today:
    -9.00p
  • 52 Week High: 445.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.09m
  • Volume: 56,123
  • Market Cap: £331.01m
  • RiskGrade: 125
  • Beta: 0.00

Latest ShareCast News

Oxford Biomedica acquires last 10pc stake in US subsidiary

By Josh White

Date: Monday 23 Jun 2025

(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.

OXB Regulatory News

OXB completes acquisition of US subsidiary 23-Jun-2025 07:00 RNS
Director/PDMR Shareholding 17-Jun-2025 18:00 RNS
Result of Annual General Meeting 11-Jun-2025 18:02 RNS
AGM Update 11-Jun-2025 07:02 RNS
Holding(s) in Company 10-Jun-2025 10:49 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 312.00p
Change Today -9.00p
% Change -2.80 %
52 Week High 445.00
52 Week Low 232.50
Volume 56,123
Shares Issued 106.09m
Market Cap £331.01m
Beta 0.00
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.39% below the market average30.39% below the market average30.39% below the market average30.39% below the market average30.39% below the market average
17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average
Price Trend
44.87% below the market average44.87% below the market average44.87% below the market average44.87% below the market average44.87% below the market average
Sector averageSector averageSector averageSector averageSector average
Income Not Available
Growth
3.55% above the market average3.55% above the market average3.55% above the market average3.55% above the market average3.55% above the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 23-Jun-2025

Time Volume / Share Price
14:24 327 @ 312.00p
14:24 164 @ 310.50p
14:24 1,406 @ 311.50p
14:24 281 @ 311.50p
14:24 430 @ 310.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page